Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 123

1.

High-density lipoprotein lipid peroxidation as a molecular signature of the risk for developing cardiovascular disease: Results from MASHAD cohort.

Samadi S, Mehramiz M, Kelesidis T, Mobarhan MG, Sahebkar AH, Esmaily H, Moohebati M, Farjami Z, Ferns GA, Mohammadpour AH, Avan A.

J Cell Physiol. 2019 Feb 19. doi: 10.1002/jcp.28276. [Epub ahead of print]

PMID:
30784041
2.

Lorcaserin treatment decreases body weight and improves cardiometabolic risk factors of obese adults: A 6-month-long, randomized, placebo-controlled, double-blind clinical trial.

Tuccinardi D, Farr OM, Upadhyay J, Oussaada SM, Mathew H, Paschou SA, Perakakis N, Koniaris A, Kelesidis T, Mantzoros CS.

Diabetes Obes Metab. 2019 Feb 6. doi: 10.1111/dom.13655. [Epub ahead of print]

PMID:
30724455
3.

Human T lymphotropic virus type 1 and risk of cardiovascular disease: High-density lipoprotein dysfunction versus serum HDL-C concentrations.

Samadi S, Abolbashari S, Meshkat Z, Mohammadpour AH, Kelesidis T, Gholoobi A, Mehramiz M, Tabadkani M, Sadabadi F, Dalirfardouei R, Ferns GA, Ghayour-Mobarhan M, Avan A.

Biofactors. 2019 Jan 29. doi: 10.1002/biof.1489. [Epub ahead of print]

PMID:
30693992
4.

The Role of Lipoproteins in Mycoplasma-Mediated Immunomodulation.

Christodoulides A, Gupta N, Yacoubian V, Maithel N, Parker J, Kelesidis T.

Front Microbiol. 2018 Jul 31;9:1682. doi: 10.3389/fmicb.2018.01682. eCollection 2018.

5.

Soluble levels of receptor for advanced glycation endproducts and dysfunctional high-density lipoprotein in persons infected with human immunodeficiency virus: ACTG NWCS332.

Kelesidis T, Kendall MA, Danoff A, Aberg JA, Currier JS, Schmidt AM.

Medicine (Baltimore). 2018 Jun;97(22):e10955. doi: 10.1097/MD.0000000000010955.

6.

Brief Report: Changes in Plasma RANKL-Osteoprotegerin in a Prospective, Randomized Clinical Trial of Initial Antiviral Therapy: A5260s.

Kelesidis T, Moser CB, Johnston E, Stein JH, Dube MP, Yang OO, McComsey GA, Currier JS, Brown TT.

J Acquir Immune Defic Syndr. 2018 Jul 1;78(3):362-366. doi: 10.1097/QAI.0000000000001679.

PMID:
29533303
7.

Low Levels of Endothelial Progenitor Cells and Their Association with Systemic Inflammation and Monocyte Activation in Older HIV-Infected Men.

Seang S, Kelesidis T, Huynh D, Park S, Moe AA, Currier JS, Lake JE.

AIDS Res Hum Retroviruses. 2018 Jan;34(1):39-45. doi: 10.1089/AID.2017.0057.

8.

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions.

Angelovich TA, Hearps AC, Maisa A, Kelesidis T, Jaworowski A.

J Vis Exp. 2017 Oct 17;(128). doi: 10.3791/56293.

9.

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein.

Sen Roy S, Nguyen HCX, Angelovich TA, Hearps AC, Huynh D, Jaworowski A, Kelesidis T.

J Vis Exp. 2017 Oct 12;(128). doi: 10.3791/56325.

10.

Dysfunctional high-density lipoprotein from HIV+ individuals promotes monocyte-derived foam cell formation in vitro.

Angelovich TA, Hearps AC, Oda MN, Borja MS, Huynh D, Homann S, Jaworowski A, Kelesidis T.

AIDS. 2017 Nov 13;31(17):2331-2336. doi: 10.1097/QAD.0000000000001642.

11.

A novel rapid and reproducible flow cytometric method for optimization of transfection efficiency in cells.

Homann S, Hofmann C, Gorin AM, Nguyen HCX, Huynh D, Hamid P, Maithel N, Yacoubian V, Mu W, Kossyvakis A, Sen Roy S, Yang OO, Kelesidis T.

PLoS One. 2017 Sep 1;12(9):e0182941. doi: 10.1371/journal.pone.0182941. eCollection 2017.

12.

Spirochetal Lipoproteins and Immune Evasion.

Christodoulides A, Boyadjian A, Kelesidis T.

Front Immunol. 2017 Mar 29;8:364. doi: 10.3389/fimmu.2017.00364. eCollection 2017. Review.

13.

Detection of Donor-Derived Microparticles in the Peripheral Blood of a Hand Transplant Recipient During Rejection.

Kim JY, Kelesidis T, Yang OO.

Transplant Direct. 2017 Feb 7;3(3):e131. doi: 10.1097/TXD.0000000000000646. eCollection 2017 Mar.

14.

Predictors of Impaired HDL Function in HIV-1 Infected Compared to Uninfected Individuals.

Kelesidis T, Oda MN, Borja MS, Yee Y, Ng KF, Huynh D, Elashoff D, Currier JS.

J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):354-363. doi: 10.1097/QAI.0000000000001383.

15.

Rhodococcus Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients1.

Vergidis P, Ariza-Heredia EJ, Nellore A, Kotton CN, Kaul DR, Morris MI, Kelesidis T, Shah H, Park SY, Nguyen MH, Razonable RR.

Emerg Infect Dis. 2017 Mar;23(3):510-512. doi: 10.3201/eid2303.160633.

16.

γH2Ax Expression as a Potential Biomarker Differentiating between Low and High Grade Cervical Squamous Intraepithelial Lesions (SIL) and High Risk HPV Related SIL.

Leventakos K, Tsiodras S, Kelesidis T, Kefala M, Kottaridi C, Spathis A, Gouloumi AR, Pouliakis A, Pappas A, Sioulas V, Chrelias C, Karakitsos P, Panayiotides I.

PLoS One. 2017 Jan 24;12(1):e0170626. doi: 10.1371/journal.pone.0170626. eCollection 2017.

17.

Assessment of Telomere Length, Phenotype, and DNA Content.

Kelesidis T, Schmid I.

Curr Protoc Cytom. 2017 Jan 5;79:7.26.1-7.26.23. doi: 10.1002/cpcy.12.

18.

Weight loss surgery in adolescents corrects high-density lipoprotein subspecies and their function.

Davidson WS, Inge TH, Sexmith H, Heink A, Elder D, Hui DY, Melchior JT, Kelesidis T, Shah AS.

Int J Obes (Lond). 2017 Jan;41(1):83-89. doi: 10.1038/ijo.2016.190. Epub 2016 Oct 26.

19.

Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection.

Kelesidis T, Jackson N, McComsey GA, Wang X, Elashoff D, Dube MP, Brown TT, Yang OO, Stein JH, Currier JS.

AIDS. 2016 Nov 13;30(17):2625-2633.

20.

Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s.

Dirajlal-Fargo S, Moser C, Brown TT, Kelesidis T, Dube MP, Stein JH, Currier J, McComsey GA.

Open Forum Infect Dis. 2016 Aug 29;3(3):ofw174. eCollection 2016 Sep.

Supplemental Content

Loading ...
Support Center